Celebrating 25 Years as a National Cancer Institute Comprehensive Cancer Center

Sarcoma Awareness

Clinical Trials

Clinical Trials Currently Enrolling at the University of Michigan

1. going to a new websiteUMMC 2009.085 Randomized, Double-Blinded, Placebo-Controlled, Multi-institutional, Phase II.5 Study of AZD0530, a Selective Src Kinase Inhibitor, in Patients with Recurrent Osteosarcoma Localized to the Lung. Primary Investigator: Dr. Scott Schuetze

2. going to a new websiteUMCC 2008.081 An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone. Primary Investigator: Dr. Scott Scheutze

3. going to a new websiteUMCC 2007.016/SARC 006 A phase II Trial of Neoadjuvant Chemotherapy in Sporadic and Neurofibromatosis Type I Associated High Grade Unresectable Malignant Peripheral Nerve Sheath Tumor. Primary Investigator: Dr. Scott Schuetze

4. going to a new websiteUMCC 2010.001 Randomized, Double-Blind, Phase II Trial of Ganglioside Vaccine +/- Adjuvant OPT-821 in Metastatic Sarcoma Patients. Primary Investigator: Dr. Rashmi Chugh

Clinical Trials Enrolling Nationally

going to a new websiteClinicalTrials.gov

going to a new websiteSouthwest Oncology Group/SWOG


back to top

Bookmark and Share

 

Cancer AnswerLine: 800-865-1125

Related Resources
Bone Metastasis